Baker Bros. Advisors as of Sept. 30, 2019
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 109 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 29.1 | $4.3B | 50M | 85.40 | |
| Incyte Corporation (INCY) | 16.1 | $2.4B | 32M | 74.23 | |
| ACADIA Pharmaceuticals (ACAD) | 10.0 | $1.5B | 41M | 35.99 | |
| Beigene (BGNE) | 9.8 | $1.4B | 12M | 122.46 | |
| Alexion Pharmaceuticals | 5.5 | $809M | 8.3M | 97.94 | |
| Amarin Corporation (AMRN) | 4.3 | $630M | 42M | 15.16 | |
| Genomic Health | 4.3 | $627M | 9.2M | 67.82 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $512M | 7.6M | 67.40 | |
| Ascendis Pharma A S (ASND) | 2.2 | $327M | 3.4M | 96.32 | |
| Invitae (NVTAQ) | 1.1 | $169M | 8.8M | 19.27 | |
| Kodiak Sciences (KOD) | 0.9 | $132M | 9.1M | 14.38 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $128M | 1.4M | 90.11 | |
| Argenx Se (ARGX) | 0.8 | $116M | 1.0M | 113.96 | |
| Heron Therapeutics (HRTX) | 0.8 | $111M | 6.0M | 18.50 | |
| Mirati Therapeutics | 0.7 | $102M | 1.3M | 77.91 | |
| Madrigal Pharmaceuticals (MDGL) | 0.7 | $101M | 1.2M | 86.22 | |
| Myokardia | 0.5 | $79M | 1.5M | 52.15 | |
| Spark Therapeutics | 0.5 | $73M | 752k | 96.98 | |
| Tricida | 0.4 | $61M | 2.0M | 30.87 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $59M | 2.7M | 21.59 | |
| Cerus Corporation (CERS) | 0.4 | $56M | 11M | 5.16 | |
| Ra Pharmaceuticals | 0.4 | $56M | 2.3M | 23.65 | |
| Igm Biosciences (IGMS) | 0.4 | $56M | 3.1M | 17.75 | |
| Dbv Technologies S A (DBVT) | 0.3 | $47M | 5.5M | 8.60 | |
| Principia Biopharma | 0.3 | $47M | 1.7M | 28.24 | |
| Gw Pharmaceuticals Plc ads | 0.3 | $43M | 371k | 115.03 | |
| Audentes Therapeutics | 0.3 | $42M | 1.5M | 28.09 | |
| Zymeworks | 0.3 | $42M | 1.7M | 24.80 | |
| Neurocrine Biosciences Inc Note 2.250 5/1 | 0.3 | $42M | 31M | 1.37 | |
| Atreca Inc Cl A (BCEL) | 0.3 | $43M | 3.5M | 12.24 | |
| Insmed (INSM) | 0.3 | $39M | 2.2M | 17.64 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $36M | 13M | 2.86 | |
| Krystal Biotech (KRYS) | 0.2 | $36M | 1.0M | 34.72 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $36M | 1.2M | 30.90 | |
| Neoleukin Therapeutics | 0.2 | $32M | 11M | 2.85 | |
| Cymabay Therapeutics | 0.2 | $29M | 5.7M | 5.12 | |
| Allakos (ALLK) | 0.2 | $27M | 340k | 78.63 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.2 | $24M | 2.8M | 8.51 | |
| Uniqure Nv (QURE) | 0.1 | $20M | 518k | 39.36 | |
| Merus N V (MRUS) | 0.1 | $21M | 1.2M | 17.82 | |
| Urogen Pharma (URGN) | 0.1 | $18M | 748k | 23.83 | |
| Axsome Therapeutics (AXSM) | 0.1 | $16M | 772k | 20.24 | |
| Xencor (XNCR) | 0.1 | $14M | 428k | 33.73 | |
| Aimmune Therapeutics | 0.1 | $14M | 674k | 20.94 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $14M | 1.2M | 12.01 | |
| Biomarin Pharma Inc convertible/ | 0.1 | $15M | 15M | 0.98 | |
| La Jolla Pharmaceuticl Com Par | 0.1 | $14M | 1.6M | 8.80 | |
| Aeglea Biotherapeutics | 0.1 | $13M | 1.7M | 7.69 | |
| Idera Pharmaceuticals | 0.1 | $13M | 4.6M | 2.89 | |
| Alkermes (ALKS) | 0.1 | $12M | 625k | 19.51 | |
| Syros Pharmaceuticals | 0.1 | $10M | 975k | 10.38 | |
| Sangamo Biosciences (SGMO) | 0.1 | $9.0M | 1000k | 9.05 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $7.1M | 1.3M | 5.31 | |
| Assembly Biosciences | 0.1 | $7.9M | 803k | 9.83 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $7.6M | 314k | 24.09 | |
| Marker Therapeutics Ord | 0.1 | $7.7M | 1.5M | 5.11 | |
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $6.7M | 893k | 7.50 | |
| Acorda Therapeutics | 0.0 | $6.4M | 2.2M | 2.87 | |
| Dermira | 0.0 | $5.8M | 907k | 6.39 | |
| Xbiotech (XBIT) | 0.0 | $5.5M | 521k | 10.46 | |
| Halozyme Therapeutics (HALO) | 0.0 | $4.7M | 300k | 15.51 | |
| Achillion Pharmaceuticals | 0.0 | $3.9M | 1.1M | 3.60 | |
| Galapagos Nv- (GLPG) | 0.0 | $3.8M | 25k | 152.64 | |
| Albireo Pharma | 0.0 | $5.0M | 250k | 20.00 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $4.0M | 113k | 34.99 | |
| Inflarx Nv (IFRX) | 0.0 | $4.4M | 1.8M | 2.47 | |
| Aravive | 0.0 | $5.0M | 664k | 7.50 | |
| Orchard Therapeutics Plc ads | 0.0 | $4.8M | 406k | 11.88 | |
| Nextcure (NXTC) | 0.0 | $4.6M | 150k | 30.85 | |
| Milestone Pharmaceuticals (MIST) | 0.0 | $5.0M | 267k | 18.65 | |
| Bluebird Bio (BLUE) | 0.0 | $3.7M | 40k | 91.82 | |
| Acceleron Pharma | 0.0 | $3.3M | 84k | 39.51 | |
| Bellicum Pharma | 0.0 | $2.8M | 2.7M | 1.05 | |
| Abeona Therapeutics | 0.0 | $2.9M | 1.3M | 2.26 | |
| Viking Therapeutics (VKTX) | 0.0 | $2.9M | 425k | 6.88 | |
| G1 Therapeutics (GTHX) | 0.0 | $2.9M | 127k | 22.78 | |
| Dova Pharmaceuticals | 0.0 | $2.9M | 102k | 27.95 | |
| Menlo Therapeutics | 0.0 | $3.1M | 700k | 4.48 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $2.6M | 175k | 15.04 | |
| Y Mabs Therapeutics (YMAB) | 0.0 | $2.7M | 103k | 26.06 | |
| Harpoon Therapeutics | 0.0 | $2.9M | 214k | 13.66 | |
| Cyclerion Therapeutics | 0.0 | $2.5M | 203k | 12.12 | |
| Ngm Biopharmaceuticals (NGM) | 0.0 | $3.5M | 250k | 13.85 | |
| Mirum Pharmaceuticals (MIRM) | 0.0 | $3.4M | 333k | 10.06 | |
| Chemocentryx | 0.0 | $1.4M | 207k | 6.78 | |
| Galmed Pharmaceuticals | 0.0 | $1.0M | 216k | 4.78 | |
| Adamas Pharmaceuticals | 0.0 | $882k | 173k | 5.11 | |
| Foamix Pharmaceuticals | 0.0 | $1.5M | 498k | 3.04 | |
| Matinas Biopharma Holdings, In (MTNB) | 0.0 | $1.3M | 2.0M | 0.63 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $1.4M | 194k | 7.38 | |
| Intellia Therapeutics (NTLA) | 0.0 | $1.7M | 129k | 13.35 | |
| Spring Bk Pharmaceuticals In | 0.0 | $2.1M | 613k | 3.44 | |
| Fulgent Genetics (FLGT) | 0.0 | $1.3M | 125k | 10.39 | |
| Sierra Oncology | 0.0 | $780k | 2.0M | 0.39 | |
| Leap Therapeutics | 0.0 | $1.1M | 979k | 1.17 | |
| Molecular Templates | 0.0 | $1.7M | 254k | 6.59 | |
| Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.1M | 122k | 9.10 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.0 | $1.9M | 157k | 12.42 | |
| Forty Seven | 0.0 | $1.6M | 250k | 6.42 | |
| Constellation Pharmceticls I | 0.0 | $861k | 133k | 6.46 | |
| Ideaya Biosciences (IDYA) | 0.0 | $1.8M | 200k | 9.00 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $598k | 580k | 1.03 | |
| Affimed Therapeutics B V | 0.0 | $588k | 200k | 2.94 | |
| Dynavax Technologies (DVAX) | 0.0 | $268k | 75k | 3.57 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $157k | 505k | 0.31 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $401k | 557k | 0.72 | |
| Evofem Biosciences | 0.0 | $514k | 102k | 5.04 | |
| Ritter Pharmaceuticals | 0.0 | $87k | 280k | 0.31 | |
| Aquestive Therapeutics (AQST) | 0.0 | $317k | 100k | 3.18 |
